Charles Roco

Charles Roco

CTO and Cofounder at Parse Biosciences
Seattle, Washington, United States

Charles Roco is Co-Founder and CTO at Parse Biosciences. He previously served as a Graduate Research Assistant at University of Washington Bioengineering and held research roles in drug delivery, microbiology, and cell mechanics at institutions including Harvard, Wyss Institute, Virginia Tech, and University of Pennsylvania.

Recent coverage

Front-page news, podcasts and videos about Charles

See all 9

Seattle’s UW research, Amazon alumni and military adjacency fuel startups building high-stakes, regulation-ready AI for biotech, finance and government

A Seattle high-school intern argues that strict school AI rules illuminated why AI must be disciplined in high-stakes domains, and describes how Seattle's research institutions (notably UW and the David Baker ecosystem), Amazon alumni, and military adjacency produce founders building accountable, regulation-ready AI for biotech, finance, and government.

Five Finalists for 2022 GeekWire Health Innovation of the Year Include A-Alpha Bio and UW Institute for Protein Design

The 2022 GeekWire Health Innovation of the Year finalists include A-Alpha Bio, Parse Biosciences, Tasso, Truveta, and the University of Washington’s Institute for Protein Design, highlighting advances in computational health approaches. Winners will be announced on May 12 at the GeekWire Awards, with community voting open until April 22.

Organizations

See all 9
  • Parse Biosciences logo
    Parse Biosciences CTO and Cofounder 2018–present · current
  • Split Biosciences Executive Officer, Director, Promoter 2018 · past
  • University of Washington Bioengineering Graduate Research Assistant 2015–2019 · past

Education

  • University of Washington Doctor of Philosophy - PhD, Bioengineering · 2015–2019
  • Virginia Tech Bachelor of Science (B.S.), Biological Systems Engineering · 2011–2015

Online

Questions about Charles Roco

Who is Charles Roco?

Charles Roco has been CTO and co-founder at Parse Biosciences since 2018. Charles previously worked as a graduate research assistant at University of Washington Bioengineering from 2015 to 2019.

What is Charles Roco known for?

Charles Roco’s research background spans drug delivery at Harvard School of Engineering and Applied Sciences and Wyss Institute for Biologically Inspired Engineering, microbiology at Virginia Tech, and cell mechanics at University of Pennsylvania.

What has Charles Roco been in the news for?

GeekWire reported in November 2025 that Qiagen would acquire Parse Biosciences in a cash deal. In April 2022, GeekWire covered the finalists for its 2022 Health Innovation of the Year award, including A-Alpha Bio and UW Institute for Protein Design. Ascend.vc reported in January 2026 on Seattle startups building regulation-ready AI for biotech, finance and government.

Which organizations is Charles Roco associated with?

Charles Roco is associated with 9 organizations, including Parse Biosciences as CTO and co-founder since 2018 and University of Washington Bioengineering as a graduate research assistant from 2015 to 2019. Charles also held drug delivery researcher roles at Harvard School of Engineering and Applied Sciences and Wyss Institute for Biologically Inspired Engineering in 2014.

Where did Charles Roco study?

Charles Roco studied Bioengineering at University of Washington for a Doctor of Philosophy - PhD from 2015 to 2019. Charles studied Biological Systems Engineering at Virginia Tech for a Bachelor of Science (B.S.) from 2011 to 2015.

Where is Charles Roco based?

Charles Roco is based in Seattle, Washington, United States.